Identification |
Name: | 5,12-Naphthacenedione,7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2-hydroxyethyl)amino]-a-L-lyxo-hexopyranosyl]oxy]-,(8S-cis)- (9CI) |
Synonyms: | N-(2-hydroxyethyl)doxorubicin |
CAS: | 103851-20-3 |
Molecular Formula: | C29H33 N O12 |
Molecular Weight: | 0 |
InChI: | InChI=1/C29H33NO12/c1-12-11-41-28(22(23(12)34)30-6-7-31)42-16-9-29(39,17(33)10-32)8-14-19(16)27(38)21-20(25(14)36)24(35)13-4-3-5-15(40-2)18(13)26(21)37/h3-5,12,16,22-23,28,30-32,34,36,38-39H,6-11H2,1-2H3 |
Molecular Structure: |
|
Properties |
Flash Point: | 487.3°C |
Boiling Point: | 882.1°Cat760mmHg |
Density: | 1.58g/cm3 |
Refractive index: | 1.696 |
Flash Point: | 487.3°C |
Safety Data |
|
|